Objective
Patent ductus arteriosus (PDA) is a common complication among premature infants, which may be responsible for prematurity‐related complications such as bronchopulmonary dysplasia (BPD). It is unclear whether different interventional methods contribute to the severity of BPD, given the original National Institute of Child Health and Human Development (NICHD) 2001 definition. To date, surgical ligation and the transcatheter approach have been equally successful in premature infants with hemodynamically significant PDA after medical treatment failure. Immediate improvement in the respiratory condition has been reported after transcatheter closure. However, the short‐term pulmonary outcome has not been clarified yet.
Methods
This retrospective study investigated infants born with a body weight <1000 g and who underwent either surgical ligation or transcatheter closure of PDA in a single tertiary institution. The infants were divided into groups according to the type of procedure (surgical ligation or transcatheter occlusion). The primary outcome was the severity of BPD at discharge or at a postmenstrual age of 36 weeks. The outcome was analyzed with logistic regression.
Results
Forty‐four patients met the inclusion criteria, of whom 14 underwent transcatheter occlusion and 30 underwent surgical ligation. The overall birth body weights and gestational age ranges were not different. The univariate model revealed an association between the procedure type and BPD severity. After adjusting for confounders, the multivariate model confirmed associations between BPD severity and procedure type and severe respiratory distress syndrome requiring surfactant.
Conclusion
Compared with the transcatheter approach, surgery for PDA in extremely preterm infants is associated with severe BPD at discharge. Further large‐scale studies are needed to determine the exact mechanism.
Objective: Patent ductus arteriosus (PDA) is a common
complication among premature infants, and it may be responsible for
prematurity-related complications, such as bronchopulmonary dysplasia
(BPD). It is unclear whether different interventional methods contribute
to the severity of BPD. To date, surgical ligation and the transcatheter
approach have shown equal success in premature infants with
hemodynamically significant PDA after medical treatment failure.
Immediate improvement in the respiratory condition after transcatheter
closure has been reported. However, the short-term pulmonary outcome has
not been clarified yet. Methods: This retrospective study
investigated infants born with a body weight less than 1000 g and
underwent either surgical ligation or transcatheter closure of PDA in a
single tertiary institution. The infants were divided into groups
according to the type of procedure (surgical ligation or transcatheter
occlusion). The primary outcome was the severity of BPD at discharge or
at post-menstrual age of 36 weeks. The outcome was analyzed with
logistic regression. Results: Forty-four patients met the
inclusion criteria, and of these, 14 underwent transcatheter occlusion
and 30 underwent surgical ligation. The overall birth body weight and
gestational age ranges were not different. The univariate model revealed
an association between the procedure type and BPD severity. The
multivariate model confirmed associations of BPD severity with procedure
type and severe respiratory distress syndrome requiring surfactant after
adjusting for confounders. Conclusion: Compared with the
transcatheter approach, surgery for PDA in extremely preterm infants is
associated with severe BPD at discharge. Further large-scale studies are
needed to determine the exact mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.